| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514572000 | Cyclic carboxylic acid containing three to five carbons or cyclic percarboxylic acid containing three to five carbons or salt thereof | 20 |
| 20090082453 | Exogenous Methyl Dihydrojasmonate for Prevention and Control of Biotic Attack in Plants - Formulations and methods for treating and preventing biotic attack, including disease and insect infestation, in plants are disclosed. The formulations include methyl dihydrojasmonate: | 03-26-2009 |
| 514573000 | Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.) | 19 |
| 20130035393 | METHOD FOR TREATING SCHIZOPHRENIA - The present invention provides a novel fatty acid derivative. The present invention also provides a method for treating schizophrenia in a mammalian subject, which comprises administering to the subject in need thereof an effective amount of a fatty acid derivative. | 02-07-2013 |
| 20090197962 | SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY - Therapeutic compounds, compositions, methods, and medicaments related thereto are disclosed herein. | 08-06-2009 |
| 20090118373 | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops - A natural formulation of compounds isolated or derived from hops which inhibit the activity of cyclooxygenase-2 (COX-2) and/or 5-lipoxygenase (5-LOX) is disclosed. The hops formulations may be administered to a mammal to treat or inhibit a pathological condition associated with the activity of COX-2 and/or 5-LOX in such a mammal. | 05-07-2009 |
| 20100267832 | METHOD FOR TREATING MACULAR DEGENERATION - Disclosed is a method for treating macular degeneration in a mammalian subject, which comprises administering to the subject in need thereof an effective amount of a 15-keto-prostaglandin compound such as 13,14-dihydro-15-keto-20-ethyl-prostaglandin F | 10-21-2010 |
| 20100087540 | PHARMACEUTICAL COMPOSITION - Provided is a pharmaceutical composition comprising: a) a prostaglandin compound; (b) a sugar alcohol; (c) a polyol; and (d) a pharmaceutically acceptable carrier. The composition of the present invention can be stored stably even in a polyethylene container. In addition, the composition of the present invention can be stored stably for a long term even if it comprises only a small amount of a preserving agent. | 04-08-2010 |
| 20080287544 | Method for Screening Substance by Measuring PPAR DELTA Activating Effect and Agent - The present invention provides a method for screening a substance having a thermogenesis enhancing effect containing a compound having an effect activating PPARĪ“, an agent containing the compound, and an agent having antidiabetic, antiobestic or visceral accumulated fat-lowering function. | 11-20-2008 |
| 20080207759 | METHOD FOR PROTECTING MITOCHONDRIA - The present invention relates to a method for protecting mitochondria from damage in a mammalian subject, which comprises administering an effective amount of a prostaglandin compound to a subject in need thereof. Also provided is a method for treating mitochondrial dysfunction as well as a condition associated with mitochondrial dysfunction in a mammalian subject, which comprises administering an effective amount of a prostaglandin compound to a subject in need thereof. | 08-28-2008 |
| 20090054524 | Methods for identifying and using IKK inhibitors - The present invention provides methods and compositions for inhibiting IKK, as well as methods and compositions for identifying compounds with activity as inhibitors of IKK, and methods and compositions for the treatment of diseases and/or conditions wherein IKK is implicated and inhibition of its activity is desired. In addition, the present invention provides methods and compositions for the improving the therapeutic activity of COX2 inhibitors, comprising administering the COX2 to a subject in combination with a compound that inhibits IKK activity. The present invention further provides compositions that comprise compounds that inhibit IKK and COX2. | 02-26-2009 |
| 20100204332 | METHOD FOR TREATING A DISEASE OR CONDITION RESPONSIVE TO OPENING OF C1C-2 CHANNEL - Disclosed is a method for prophylactic or therapeutic treatment of a condition or disease responsive to opening of ClC-2 channel, which comprises the step of administrating an effective amount of a ClC-2 channel opener to a subject in need of said treatment. According to the invention, a tissue or organ to be transplanted can also be treated with the ClC-2 channel opener. | 08-12-2010 |
| 20100204331 | PROSTAGLANDIN DERIATIVE-CONTAINING AQUEOUS LIQUID PREPARATION - Provided is an aqueous liquid preparation comprising: (a) any one of a prostaglandin derivative being represented by the following formula (I), a pharmaceutically acceptable salt thereof and a hydrate thereof; and (b) at least one polyol of glycerin, propylene glycol, dipropylene glycol and 1,3-butylene glycol. | 08-12-2010 |
| 20100179222 | COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES - Cosmetic or pharmaceutical compositions comprising compounds of formula (I) and the corresponding salts thereof: | 07-15-2010 |
| 20100324142 | HYDROCORTISONE DERIVATIVES AND USE THEREOF FOR THERAPEUTIC OR COSMETIC INDICATIONS - The present invention relates to hydrocortisone derivatives, the method of production thereof and the therapeutic or cosmetic use thereof to combat hair loss or in the treatment of cutaneous physiopathologies. | 12-23-2010 |
| 20100069497 | COMPOSITIONS COMPRISING JASMONIC ACID DERIVATIVES AND USE OF THESE DERIVATIVES - Cosmetic or pharmaceutical compositions comprising compounds of formula (I) and the corresponding salts thereof: | 03-18-2010 |
| 20080200550 | Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein - Inhibition of HIV-1 replication by disrupting the processing of the viral Gag capsid (CA) protein (p24) from the CA-spacer peptide 1 (SP1) protein precursor (p25) is disclosed. Amino acid sequences containing a mutation in the Gag p25 protein, with the mutation resulting in a decrease in the inhibition of processing of p25 to p24 by dimethylsuccinyl betulinic acid or dimethylsuccinyl betulin, polynucleotides encoding such mutated sequences and antibodies that selectively bind such mutated sequences are also included. Methods of inhibiting, inhibitory compounds and methods of discovering inhibitory compounds that target proteolytic processing of the HIV Gag protein are included. In one embodiment, such compounds inhibit the interaction of the HIV protease enzyme with Gag by binding to Gag rather than to the protease enzyme. In another embodiment, viruses or recombinant proteins that contain mutations in the region of the Gag proteolytic cleavage site can be used in screening assays to identify compounds that target proteolytic processing. | 08-21-2008 |
| 20100184862 | PROSTACYCLIN DERIVATIVES - This invention relates to novel prostacyclin derivatives, their acceptable acid addition salts, solvates, hydrates and polymorphs thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by prostacyclin, and in particular those diseases and conditions beneficially treated by dilators of systemic and pulmonary arterial vascular beds or by platelet aggregation inhibitors. | 07-22-2010 |
| 20120022164 | EXTERNAL PREPARATION COMPRISING PROSTAGLANDIN DERIVATIVE - Provided is an external preparation comprising a complex containing: any one of a prostaglandin derivative, a pharmaceutically acceptable salt thereof and a hydrate thereof; and cyclodextrin, the prostaglandin derivative being represented by the following formula (I): | 01-26-2012 |
| 20120322876 | COSMETIC COMPOSITION COMPRISING A JASMONIC ACID COMPOUND - The invention relates to a cosmetic composition comprising, in a physiologically acceptable aqueous medium, a jasmonic acid compound and a non-ionic associative polyurethane/polyether polymer. | 12-20-2012 |
| 20100234466 | Compositions and Methods for Reducing Body Fat - The present invention relates to compositions, such as bimatoprost, latanoprost and travoprost, and methods to reduce fat in the body of an individual, for example, by topical administration, injection, and/or implantation of such compositions. | 09-16-2010 |
| 20120088836 | USE OF A JASMONIC ACID COMPOUND FOR TREATING GREASY SKIN - The invention relates to a method for cosmetically treating oily skin, including the topical application onto the skin of a composition containing a jasmonic acid compound in a physiologically acceptable medium. | 04-12-2012 |
